Hollencrest Capital Management
Source: SEC Form 13F · as of Mar 2026Hollencrest Capital Management holds 55 biotech & pharma companies tracked by BioSniper, totaling $65.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
55
Total value held
$65.4M
BioSniper AIPage evidence connected
Prepared research question
What matters most for UnitedHealth Group Incorporated Common Stock (DE) (UNH)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.